EGFR and radiation pneumonitis: It was found that although the incidence of ≥ grade 2 radiation pneumonia was higher than that of synchronous radiotherapy and chemotherapy, the use of Icotinib, ipsilateral lung V30 ≤ 34%, or EGFR-TKI overlapping with chest radiotherapy for ≤ 20 days can be reduced (38).